SEARCH · PubMed Health

Results for “Muscle mass”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 91 records · Page 5Linked to original sources

PubMedDate not supplied

Left ventricular papillary muscle mass: relationship to left ventricular mass and volumes by magnetic resonance imaging.

OBJECTIVE: To evaluate the effect of papillary muscle mass on the calculation of left ventricular (LV) function and mass and to determine the relationship between papillary muscle mass with body size and sex. METHODS: Cardiac magnetic resonance imaging examinations from 50 men and 50 women were randomly selected from the Multi-Ethnic Study of Atherosclerosis database. The contours of the papillary muscles were traced manually, and the LV wall contours were outlined semiautomatically based on short-axis images. Papillary muscle mass, LV mass, and volumes were calculated. RESULTS: Inclusion of the papillary muscles results in significantly higher total LV mass values (P<0.001) and lower end-diastolic volume values (P<0.001) compared with measurements excluding papillary muscles from the LV mass. Papillary muscle mass accounts for 8.9% of the total LV mass and is correlated with LV wall mass (r=0.81, P<0.001). CONCLUSION: Papillary muscle mass significantly affects LV volumes and mass determined by cine magnetic resonance imaging.

Aged↗

PubMed1983

Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method.

Measuring muscle mass is an important component of the nutritional assessment examination and a suggested index of this body space is the 24-h urinary excretion of creatinine. The method originated from studies in a variety of animal species in whom early workers found a parallelism between total body creatine and urinary excretion of creatinine. Assuming that nearly all creatine was within muscle tissue, that muscle creatine content remained constant and that creatinine was excreted at a uniform rate, an obvious "corollary" was that urinary creatinine was proportional to muscle mass. The so-called "creatinine equivalence" (kg muscle mass/g urinary creatinine) ranged experimentally from 17 to 22. One of the limiting factors in firmly establishing this constant and its associated variability was (and is) the lack of another totally acceptable noninvasive technique of measuring muscle mass to which the creatinine method could (or would) be compared. An improved understanding of creatine metabolism and a variety of clinical studies in recent years has tended to support the general validity of this approach. However, specific conditions have also been established in which the method becomes either inaccurate or invalid. While creatinine excretion may serve as a useful approximation of muscle mass in carefully selected subjects, there remains a need for accurate and practical indices of muscle mass for use in the individuals in whom the method cannot be reliably applied.

Adult↗

PubMed2006

Cyclosporin-A does not affect skeletal muscle mass during disuse and recovery.

Cyclosporin-A (CsA) is an immunosuppressive drug that acts as an inhibitor of calcineurin, a calcium phosphatase that has been suggested to play a role in skeletal muscle hypertrophy. The aim of the present study was to determine the effect of CsA administration (25 mg kg(-1) day(-1)) on skeletal muscle mass and phenotype during disuse and recovery. Male Wistar rats received vehicle (N = 8) or CsA (N = 8) during hind limb immobilization (N = 8) and recovery (N = 8). Muscle weight (dry/wet) and cross-sectional area were evaluated to verify the effect of CsA treatment on muscle mass. Muscle phenotype was assessed by histochemistry of myosin ATPase. CsA administration during immobilization and recovery did not change muscle/body weight ratio in the soleus (SOL) or plantaris (PL). Regarding muscle phenotype, we observed a consistent slow-to-fast shift in all experimental groups (immobilized only, receiving CsA only, and immobilized receiving CsA) as compared to control in both SOL and PL (P < 0.05). During recovery, no difference was observed in SOL or PL fiber type composition between the experimental recovered group and recovered group receiving CsA compared to their respective controls. Considering the muscle/body weight ratio, CsA administration does not maximize muscle mass loss induced by immobilization. Our results also indicate that CsA fails to block skeletal muscle regrowth after disuse. The present data suggest that calcineurin inhibition by CsA modulates muscle phenotype rather than muscle mass.

Animals↗

PubMed2000

Standardized thigh muscle area measured by computed axial tomography as an alternate muscle mass index for nutritional assessment of hemodialysis patients.

BACKGROUND: Quantification of muscle mass, which represents the largest protein pool in the body, is important for nutritional assessment but is difficult to achieve with conventional methods in hemodialysis patients. OBJECTIVE: We measured the cross-sectional area of the thigh occupied by muscle by using computed tomography and compared this with other muscle mass indicators. DESIGN: Thigh muscle area (TMA) was examined and correlated with creatinine production and various nutritional indexes in 163 patients undergoing hemodialysis. Where appropriate, TMA was expressed relative to bone area in the thigh (TBA) to avoid the influence of body size. RESULTS: TMA was highly correlated with creatinine production as measured in the spent dialysate (r = 0.85, P < 0.001), indicating that TMA substantially reflects total-body muscle mass. TMA standardized for TBA was negatively correlated with age and positively correlated with other nutritional indicators including body weight, body mass index, serum albumin, serum transthyretin, and protein catabolic rate. Multiple regression analysis revealed that of these variables, age, serum albumin, and protein catabolic rate independently predicted TMA standardized for TBA. By using correlations with various nutritional indicators, we concluded that patients with a value <10.0 for TMA standardized for TBA were likely to be malnourished whereas those with a value >13.0 were likely to be well nourished. CONCLUSIONS: These results indicate that TMA standardized for TBA, measured by computed tomography, is a reliable indicator of muscle mass that could be used for nutritional assessment of hemodialysis patients.

Aged↗

PubMed1997

Bone and muscle mass after femoral neck fracture. A controlled quantitative computed tomography study of osteosynthesis versus primary total hip arthroplasty.

The cortical bone mineral density (BMD), bone volume, bone mass and muscle volume of the thigh, and the BMD of the distal femur and proximal tibia were measured quantified by quantitative computed tomography (QCT) after an operation for a displaced femoral neck fracture. Twenty patients were randomized to osteosynthesis or total hip arthroplasty (THA). Both legs were scanned after 18 months, and the operated side was compared with the healthy side. Clinical assessment was performed with a Harris hip score. A reference group of 9 patients, who had undergone THA because of arthrosis, was chosen. In the fracture patients, we found a 9% decrease in bone mass and muscle volume of the middle femur. The BMD of the distal femur and proximal tibia showed a more marked osteopenia. There was no difference in these parameters between the two groups. In the reference group of operated arthrosis patients, we did not find any differences between sides postoperatively. After the operation, the fracture patients had a lower Harris score than the arthrosis patients, and this was most pronounced among those who had undergone osteosynthesis. The finding of a marked osteopenia after a femoral neck fracture, irrespective of treatment, but no bone loss after THA because of arthrosis, implies that patients with a femoral neck fracture are more sensitive to osteopenia, and that the bone loss is not proportional to the operative trauma.

Aged↗

PubMed2004

Satellite cell regulation of muscle mass is altered at old age.

Muscle mass is decreased with advancing age, likely due to altered regulation of muscle fiber size. This study was designed to investigate cellular mechanisms contributing to this process. Analysis of male Fischer 344 X Brown Norway rats at 6, 20, and 32 mo of age demonstrated that, even though significant atrophy had occurred in soleus muscle by old age, myofiber nuclear number did not change, resulting in a decreased myonuclear domain. Also, the number of centrally located nuclei was significantly elevated in soleus muscle of 32-mo-old rats, correlating with an increase in gene expression of MyoD and myogenin. Whereas total 5'-bromo-2'deoxyuridine (BrdU)-positive nuclei were decreased at older ages, BrdU-positive myofiber nuclei were increased. These results suggest that, with age, loss of muscle mass is accompanied by increased myofiber nuclear density that involves fusion of proliferative satellite cells, resembling ongoing regeneration. Interestingly, centrally located myofiber nuclei were not BrdU labeled. Rats were subjected to hindlimb suspension (HS) for 7 or 14 days and intermittent reloading during HS for 1 h each day (IR) to investigate how aging affects the response of soleus muscle to disuse and an atrophy-reducing intervention. After 14 days of HS, soleus muscle size was decreased to a similar extent at all three ages. However, myofiber nuclear number and the total number of BrdU-positive nuclei decreased with HS only in the young rats. IR was associated with an attenuation of atrophy in soleus muscles of 6- and 20- but not 32-mo-old rats. Furthermore, IR was associated with an increase in BrdU-positive myofiber nuclei only in young rats. These data indicate that altered satellite cell function with age contributes to the impaired response of soleus muscle to an intervention that attenuates muscle atrophy in young animals during imposed disuse.

Adaptation, Physiological↗

PubMed1988

Determination of left ventricular wall thickness and muscle mass by intravenous digital subtraction angiocardiography: validation of the method.

Left ventricular (LV) wall thickness and muscle mass are important measures of LV hypertrophy. In 24 patients LV end-diastolic wall thickness and muscle mass were determined (two observers) by digital subtraction angiocardiography (DSA) and conventional LV angiocardiography (LVA). Wall thickness was determined over the anterolateral wall of the left ventricle according to the technique of Rackley (method 1) or by planimetry (method 2). Seventeen patients were studied at rest and seven during dynamic exercise. Wall thickness correlated well between LVA and DSA; the best correlations were obtained by a combined subtraction mode using either method 1 or 2 (method 1, r greater than or equal to 0.80; method 2, r greater than or equal to 0.75). The standard error of estimate of the mean (SEE) was slightly lower for method 2 (less than or equal to 10%) than for method 1 (less than or equal to 13%). DSA significantly overestimated wall thickness by 5-7% with method 1 and underestimated by 12-14% with method 2. Muscle mass correlated well between LVA and DSA; the SEE was less than or equal to 15% for method 1 and less than or equal to 12% for method 2. Overestimation of muscle mass by DSA was 7-11% with method 1 and underestimation was 13-15% with method 2. It is concluded that LV wall thickness can be determined accurately by DSA with an SEE ranging between 10 and 13%. Determination of LV muscle mass is slightly less accurate and the SEE is slightly larger ranging between 13 to 17%. With method 1, wall thickness and muscle mass were overestimated and with method 2 underestimated.

Adult↗

PubMed1993

Knee function after operation for malignancy of the distal femur. Quadriceps muscle mass and knee extension strength in 21 patients with hinged endoprostheses.

We evaluated quadriceps muscle mass and knee extension strength in 21 patients after resection and endoprosthetic replacement of the distal femur for malignant bone tumor. In all cases, a modular cementless, hinged prosthesis had been used. The mean follow-up period was 4 (2-9) years. Muscle mass was measured ultrasonographically, and strength isokinetically with a Cybex 6000 dynamometer. All the data for the operated side are given as percentage of the non-operated side. The average quadriceps mass was 48 (27-70) percent. The average peak torque was 31 (14-48) and 36 (18-55) percent at the speed of 30 degrees/s and 90 degrees/s, respectively. The reduction in extension strength became greater with increasing flexion. There was a moderate correlation between muscle mass and muscle strength. Most of the patients who had kept more than 40 percent of the quadriceps mass had more than 30 percent peak torque. Patients with excellent function (Enneking 1987) had more quadriceps muscle mass and higher strength than those that were merely good with the borderline at about 40 percent muscle mass.

Adolescent↗

PubMed1997

Sarcopenia: assessment of muscle mass.

Despite general information that skeletal muscle mass is the largest organ in the body and despite increased awareness of the importance of skeletal muscle in biological function, methods and techniques for its routine assessment in humans are generally lacking. One important reason for the paucity of assessment tools is the relative lack of direct data on anatomical skeletal muscle mass in humans.

Absorptiometry, Photon↗

PubMed2006

Oxygen cost of dynamic or isometric exercise relative to recruited muscle mass.

BACKGROUND: Oxygen cost of different muscle actions may be influenced by different recruitment and rate coding strategies. The purpose of this study was to account for these strategies by comparing the oxygen cost of dynamic and isometric muscle actions relative to the muscle mass recruited via surface electrical stimulation of the knee extensors. METHODS: Comparisons of whole body pulmonary delta VO2 were made in seven young healthy adults (1 female) during 3 minutes of dynamic or isometric knee extensions, both induced by surface electrical stimulation. Recruited mass was quantified in T2 weighted spin echo magnetic resonance images. RESULTS: The delta VO2 for dynamic muscle actions, 242 +/- 128 ml x min(-1) (mean +/- SD) was greater (p = 0.003) than that for isometric actions, 143 +/- 99 ml x min(-1). Recruited muscle mass was also greater (p = 0.004) for dynamic exercise, 0.716 +/- 282 versus 0.483 +/- 0.139 kg. The rate of oxygen consumption per unit of recruited muscle (VO2(RM)) was similar in dynamic and isometric exercise (346 +/- 162 versus 307 +/- 198 ml x kg(-1) x min(-1); p = 0.352), but the VO2(RM) calculated relative to initial knee extensor torque was significantly greater during dynamic exercise 5.1 +/- 1.5 versus 3.6 +/- 1.6 ml x kg(-1) x Nm(-1) x min(-1) (p = 0.019). CONCLUSION: These results are consistent with the view that oxygen cost of dynamic and isometric actions is determined by different circumstances of mechanical interaction between actin and myosin in the sarcomere, and that muscle recruitment has only a minor role.

Journal Article↗

PubMed2005

Estimation of total-body skeletal muscle mass in children and adolescents.

PURPOSE: The estimation of total-body skeletal muscle mass (SMM) has been predicted in healthy adults using anthropometric measurements and urine creatinine excretion. SMM measurement is compulsory to evaluate exercise performance and the influence of physical training on muscle mass. However, there is a lack of information on children and adolescents when quantifying appendicular skeletal muscle mass. METHODS: Thirty-nine Caucasian children and adolescents (male and female, 7-16 yr old) and 20 adults (men and women, 20-24 yr old) were tested for total-body SMM using dual-energy x-ray absorptiometry measurement (DEXA), anthropometric measurements (ANTHR), and urine creatinine (UCrn) determination. Skinfold thickness and circumference were measured at mid-arm (CAG), mid-thigh (CTG), and mid-calf (CCG) and the skin-corrected circumferences (cm), together with height (Ht; m), age (yr), and sex (0 for female, 1 for male). The UCrn excretion (g.24 h(-1)) was also determined in all subjects. The ANTHR and UCrn measurements were then compared with DEXA as reference value. RESULTS: The multiple linear regression from anthropometric measurements gave the following equation to evaluate the total-body skeletal muscle mass (SMM) in children and adolescents: SMM (kg) = Ht x [(0.0064 x CAG) + (0.0032 x CTG) + (0.0015 x CCG)(2)] + (2.56 x sex) + (0.136 x age). The prediction of SMM from a 24-h urine collection was obtained with the following equation: SMM (kg) = (10.62 x Crn) + 6.63. The correlation coefficient (r(2)) was 0.966 and 0.710 for the anthropometric and creatinine methods, respectively (P < 0.001). CONCLUSION: Besides DEXA technique, the determination of total-body skeletal muscle mass in children and adolescents can be highly validated with satisfactory confidence by simple anthropometric measurements or 24-h urine creatinine excretion.

Absorptiometry, Photon↗

PubMed1991

Limits of reproducibility of cross-sectional echocardiographic measurements of left ventricular muscle mass.

The total intrinsic variability of echocardiographically determined left ventricular muscle mass was evaluated in this study. Cross-sectional left ventricular echocardiograms were made in 13 normal volunteers (8 men, 5 women), ages 31 to 41 years (mean 36) with an interval period of about eleven months. We used the parasternal long axis view, the short axis view at the papillary muscle level and the four-chamber view from the apex. M-mode recordings were made from the parasternal long-axis view. Left ventricular muscle mass from M-mode recordings was calculated using a simple cube formula and from cross-sectional echo cardiography with an area-length formula. The reproducibility of the left ventricular muscle mass for the methods was respectively 10 +/- 6% and 5 +/- 3% (mean +/- SD). From both methods cross-sectional echo is the method of choice for determining left ventricular muscle mass in man in sequential studies.

Adult↗

PubMed2003

Validation of a bioelectrical impedance analysis equation to predict appendicular skeletal muscle mass (ASMM).

RATIONALE: Appendicular skeletal muscle mass (ASMM) is useful in the evaluation of nutritional status because it reflects the body muscle protein mass. The purpose of this study was to validate, against dual-energy X-ray absorptiometry (DEXA), a BIA equation to predict ASMM to be used in volunteers and patients. METHOD: Healthy men (n = 246 men, BMI 25.3+/-2.9 kg/m(2)) and women (n =198, 24.1+/-3.6 kg/m(2)), and heart, lung and liver transplant patients (213 men, BMI of 24.6+/-4.4 kg/m(2); 113 women, BMI 23.0+/-5.2 kg/m(2)) were measured by BIA (Xitron Technologies) and DEXA (Hologic QDR 4500). A BIA equation to predict ASMM (kg) that included height(2)/resistance, weight, gender, age and reactance, was developed by means of multiple regressions. [table: see text] Mean difference (Bland-Altman) for volunteers was 0.1+/-1.1 kg, r =0.95, SEE 1.12 kg and for patients -0.4+/-1.5 kg, r =0.91, SEE 1.5 kg. Best fitted multiple regression equation was -4.211 + (0.267 x height2 / resistance) + (0.095 x weight)+(1.909 x sex (men = 1, women = 0)) + (-0.012 x age) + (0.058 x reactance). CONCLUSIONS: BIA permits the prediction of ASMM in healthy volunteers and patients between 22 and 94 years of age. A slightly larger, though clinically not significant, error was noted in patients.

Absorptiometry, Photon↗

PubMed1997

A new formula for population-based estimation of whole body muscle mass in males.

A new equation to estimate muscle mass in males was developed using parameters common to the 1981 Canada Fitness Survey and the male cadaver data of Martin et al. (1990b). The cadavers (N = 12) were randomly divided into two groups. The equation was developed on cadaver Group A and then validated on Group B. Once the equation with the most suitable variables was validated on Group B, it was redeveloped on combined data from Groups A and B. The final equation is as follows: muscle mass (gm) = Ht (0.031MUThG2 + 0.064CCG2 + 0.089CAG2) - 3,006; adjusted R2 = .96, SEE = 1,488 gm, F = 87.5, p = .0001. Variables (in cm) were Ht, height; MUThG, modified upper thigh girth; CCG, corrected calf girth; and CAG, corrected arm girth. The predictive ability of this equation was comparable to the original equation of Martin et al. (1990b) and can be a valuable tool for muscle mass estimation of male subjects in the 1981 Canada Fitness Survey.

Aged↗

PubMed2001

Translational control of protein synthesis: implications for understanding changes in skeletal muscle mass.

Gain or loss of skeletal muscle mass is due largely to the establishment of an imbalance between rates of protein synthesis and degradation. A key determinant of the rate of protein synthesis is translation initiation, a process regulated in part through binding of initiator methionyl-tRNA (met-tRNAi) and messenger RNA (mRNA) to a 40S ribosomal subunit. Either the met-tRNAi or mRNA binding step can become limiting for protein synthesis. Furthermore, the mRNA binding step can modulate translation of specific mRNAs with or without changes in the overall rate of protein synthesis. This report highlights molecular mechanisms involved in mediating control of the mRNA binding step in translation initiation. Particular attention is given to the effect of exercise on this step and to how the branched-chain amino acid leucine stimulates muscle protein synthesis after exercise. Potential mechanisms for exercise-induced increase in muscle mass are discussed.

Animals↗

PubMed2005

Muscle mass loss in Rhesus monkeys: age of onset.

Sarcopenia, the decline in skeletal muscle mass and function with age, contributes to increased frailty and decreased functional performance in the aging human population. The negative health consequences of muscle mass loss emphasize the need for development of a nonhuman primate model for the prevention or attenuation of sarcopenia. The age of onset for muscle mass loss in Rhesus macaques was determined using three datasets; (i) dual-energy X-ray absorptiometry (DXA) data from a cross-sectional study of 90 adult Rhesus monkeys; (ii) lean tissue mass and estimated skeletal muscle mass (ESM) from 727 DXA scans taken in 38 monkeys in a long-term, longitudinal aging study; and, (iii) quadriceps weights taken at necropsy from 13 male and 28 female Rhesus monkeys. These data indicate that both male and female Rhesus monkeys develop sarcopenia with age. The onset of sarcopenia is 14.1 +/- 2.8 years in females and 15.8 +/- 2.5 years in males. Muscle loss reaches 20% in males by 23.2 years of age and in females by 24.5 years of age. Furthermore, our data indicate percentage declines in ESM similar to those seen in humans with advancing age. These data support the suitability of the Rhesus monkey as a primate sarcopenia model.

Absorptiometry, Photon↗

PubMed2006

Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass.

BACKGROUND: Myostatin negatively regulates skeletal muscle growth. Myostatin knockout mice exhibit muscle hypertrophy and decreased interstitial fibrosis. We investigated whether a plasmid expressing a short hairpin interfering RNA (shRNA) against myostatin and transduced using electroporation would increase local skeletal muscle mass. METHODS: Short interfering RNAs (siRNAs) targeting myostatin were co-transfected with a myostatin-expressing plasmid into HEK293 cells and identified for myostatin silencing by Western blot. Corresponding shRNAs were cloned into plasmid shRNA expression vectors. Myostatin or a randomer negative control shRNA plasmid was injected and electroporated into the tibialis anterior or its contralateral muscle, respectively, of nine rats that were sacrificed after 2 weeks. Six other rats received a beta-galactosidase reporter plasmid and were sacrificed at 1, 2, and 4 weeks. Uptake of plasmid was examined by beta-galactosidase expression, whereas myostatin expression was determined by real-time polymerase chain reaction (PCR) and Western blotting. Muscle fiber size was determined by histochemistry. Satellite cell proliferation was determined by PAX7 immunohistochemistry. Myosin heavy chain type II (MHCII) expression was determined by Western blot. RESULTS: beta-Galactosidase reporter plasmid was expressed at 1 and 2 weeks but diminished by 4 weeks in tibialis anterior skeletal muscle. Myostatin shRNA reduced myostatin mRNA and protein expression by 27 and 48%, respectively. Tibialis anterior weight, fiber size, and MHCII increased by 10, 34, and 38%, respectively. Satellite cell number was increased by over 2-fold. CONCLUSIONS: This is the first demonstration that myostatin shRNA gene transfer is a potential strategy to increase muscle mass.

Animals↗

PubMed1998

Appendicular skeletal muscle mass, physical activity, and cognitive status in patients with Alzheimer's disease.

OBJECTIVE: To examine the interrelations among appendicular skeletal muscle mass and physical activity, energy intake, and cognitive status in free-living patients with AD. BACKGROUND: Increasing disease severity in AD patients may contribute to poor nutritional status and loss of skeletal muscle mass. This may lead to impaired physical function and loss of functional independence. METHODS: Participants in our study were 30 noninstitutionalized AD patients (74 +/- 8 years) and 30 healthy age- and body mass index-matched control subjects (73 +/- 7 years). We measured appendicular skeletal muscle mass by dual-energy X-ray absorptiometry, energy expenditure by doubly labeled water, and energy intake by food diaries. RESULTS: As expected, the AD group had lower Mini-Mental State Examination scores than the control subjects (p < 0.05). No differences in energy intake or energy expenditure and its components were noted between the groups. Higher levels of appendicular muscle mass in AD patients were associated with increased energy expenditure of physical activity (r = 0.52, p < 0.01) and daily energy intake (r = 0.49, p = 0.01). Cognitive status was not related to appendicular muscle mass, daily energy intake, or energy expenditure of physical activity in AD patients. CONCLUSIONS: Higher levels of physical activity and energy intake are associated with higher appendicular skeletal muscle mass in AD patients. Nutritional and physical activity interventions may represent practical and inexpensive strategies in their therapeutic management.

Adipose Tissue↗